37441 |
Oncology |
HLA-corrected tumor mutation burden and homologous recombination de fi... |
ANN ONCOL 2020 10.1016/j.annonc.2020.04.004 |
안명주 |
2020 |
37440 |
Oncology; Immunology |
Clinical advantage of targeted sequencing for unbiased tumor mutationa... |
J IMMUNOTHER CANCER 2020 10.1136/jitc-2020-001199 |
안명주 |
2020 |
37439 |
Oncology |
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Posit... |
J CLIN ONCOL 2020 10.1200/JCO.20.00505 |
안명주 |
2020 |
37438 |
Oncology |
Biomarker-driven phase 2 umbrella trial study for patients with recurr... |
CANCER 2020 10.1002/cncr.33048 |
안명주 |
2020 |
37437 |
Multidisciplinary Sciences |
An increase of CD8(+)T cell infiltration following recurrence is a goo... |
SCI REP-UK 2020 10.1038/s41598-020-77036-8 |
안명주 |
2020 |
37436 |
Genetics & Heredity |
Single-cell transcriptome analysis of tumor and stromal compartments o... |
GENOME MED 2020 10.1186/s13073-020-00776-9 |
박준오 |
2020 |
37435 |
Oncology |
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclit... |
J CLIN ONCOL 2020 10.1200/JCO.20.00590 |
박준오 |
2020 |
37434 |
Pharmacology & Pharmacy |
Phase I clinical trial of KML001 monotherapy in patients with advanced... |
EXPERT OPIN INV DRUG 2020 10.1080/13543784.2020.1804855 |
박준오 |
2020 |
37433 |
Oncology |
Clinical and molecular distinctions in patients with refractory colon ... |
THER ADV MED ONCOL 2020 10.1177/1758835920965842 |
박준오 |
2020 |
37432 |
Oncology |
A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Rep... |
CANCER RES TREAT 2020 10.4143/crt.2020.218 |
박준오 |
2020 |